Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: A system for studying Rett syndrome

Brain Research

Volumn 1360, Issue , 2010, Pages 17-27

  Okabe, Yasunori ^a,b   Kusaga, Akira ^a,b   Takahashi, Tomoyuki ^a,b   Mitsumasu, Chiaki ^a,b   Murai, Yoshinaka ^b   Tanaka, Eiichiro ^a,b   Higashi, Hideho ^b   Matsuishi, Toyojiro ^a,b   Kosai, Ken Ichiro ^a,b,c  

^a KURUME UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Embryonic stem cell; MeCP2; Rett syndrome

Indexed keywords

ADENOVIRUS VECTOR; BETA TUBULIN; BETA TUBULIN TYPE 3; DOPAMINE; METHYL CPG BINDING PROTEIN 2; NESTIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MATURATION; CELL STRUCTURE; DOPAMINE RELEASE; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; GENE LOCUS; GENE MUTATION; GLIOGENESIS; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; POTASSIUM CURRENT; PRIORITY JOURNAL; RETT SYNDROME; SODIUM CURRENT;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONE CELLS; DOPAMINE; ELECTROPHYSIOLOGICAL PHENOMENA; EMBRYONIC STEM CELLS; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL STEM CELLS; NEUROGENESIS; NEUROGLIA; NEURONS; RETT SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957963261     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.090     Document Type: Article

References (41)

1. N.J. Allen, and B.A. Barres Neuroscience: Glia-more than just brain glue Nature 457 2009 675 677
2. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet. 23 1999 185 188
3. D.D. Armstrong Neuropathology of Rett syndrome Ment. Retard. Dev. Disabil. Res. Rev. 8 2002 72 76
4. N. Ballas, D.T. Lioy, C. Grunseich, and G. Mandel Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology Nat. Neurosci. 12 2009 311 317
5. G. Biella, F. Di Febo, D. Goffredo, A. Moiana, V. Taglietti, L. Conti, E. Cattaneo, and M. Toselli Differentiating embryonic stem-derived neural stem cells show a maturation-dependent pattern of voltage-gated sodium current expression and graded action potentials Neuroscience 149 2007 38 52
6. T. Bienvenu, and J. Chelly Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized Nat. Rev. Genet. 7 2006 415 426
7. M. Chahrour, and H.Y. Zoghbi The story of Rett syndrome: from clinic to neurobiology Neuron 56 2007 422 437
8. M. Chahrour, S.Y. Jung, C. Shaw, X. Zhou, S.T. Wong, J. Qin, and H.Y. Zoghbi MeCP2, a key contributor to neurological disease, activates and represses transcription Science 320 2008 1224 1229
9. R.Z. Chen, S. Akbarian, M. Tudor, and R. Jaenisch Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice Nat. Genet. 27 2001 327 331
10. S.H. Chen, X.H. Chen, Y. Wang, K. Kosai, M.J. Finegold, S.S. Rich, and S.L. Woo Combination gene therapy for liver metastasis of colon carcinoma in vivo Proc. Natl. Acad. Sci. U. S. A. 92 1995 2577 2581
11. C. Chiron, C. Bulteau, C. Loc'h, C. Raynaud, B. Garreau, A. Syrota, and B. Maziere Dopaminergic D2 receptor SPECT imaging in Rett syndrome: increase of specific binding in striatum J. Nucl. Med. 34 1993 1717 1721
12. J.G. Corbin, N. Gaiano, S.L. Juliano, S. Poluch, E. Stancik, and T.F. Haydar Regulation of neural progenitor cell development in the nervous system J. Neurochem. 106 2008 2272 2287
13. K. Deguchi, B.A. Antalffy, L.J. Twohill, S. Chakraborty, D.G. Glaze, and D.D. Armstrong Substance P immunoreactivity in Rett syndrome Pediatr. Neurol. 22 2000 259 266
14. E. Ficker, and U. Heinemann Slow and fast transient potassium currents in cultured rat hippocampal cells J. Physiol. 445 1992 431 455
15. J. Guy, B. Hendrich, M. Holmes, J.E. Martin, and A. Bird A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome Nat. Genet. 27 2001 322 326
16. S. Ide, M. Itoh, and Y. Goto Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse Neurosci. Lett. 386 2005 14 17
17. K.A. Jellinger Rett syndrome-an update J. Neural Transm. 110 2003 681 701
18. T. Kawai, T. Takahashi, M. Esaki, H. Ushikoshi, S. Nagano, H. Fujiwara, and K. Kosai Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2 Circ. J. 68 2004 691 702
19. H. Kawasaki, K. Mizuseki, S. Nishikawa, S. Kaneko, Y. Kuwana, S. Nakanishi, S.I. Nishikawa, and Y. Sasai Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity Neuron 28 2000 31 40
20. N. Kishi, and J.D. Macklis MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions Mol. Cell. Neurosci. 27 2004 306 321
21. S. Kriaucionis, and A. Bird The major form of MeCP2 has a novel N-terminus generated by alternative splicing Nucleic Acids Res. 32 2004 1818 1823
22. A. Lekman, I. Witt-Engerstrom, B. Holmberg, A. Percy, L. Svennerholm, and B. Hagberg CSF and urine biogenic amine metabolites in Rett syndrome Clin. Genet. 37 1990 173 178
23. I. Maezawa, S. Swanberg, D. Harvey, J.M. LaSalle, and L.W. Jin Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions J. Neurosci. 29 2009 5051 5061
24. T. Matsuishi, Y. Yamashita, and A. Kusaga Neurobiology and neurochemistry of Rett syndrome Brain Dev. 23 Suppl 1 2001 S58 S61
25. G.N. Mnatzakanian, H. Lohi, I. Munteanu, S.E. Alfred, T. Yamada, P.J. MacLeod, J.R. Jones, S.W. Scherer, N.C. Schanen, M.J. Friez, J.B. Vincent, and B.A. Minassian A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome Nat. Genet. 36 2004 339 341
26. Y. Murai, and T. Akaike Orexins cause depolarization via nonselective cationic and K+ channels in isolated locus coeruleus neurons Neurosci. Res. 51 2005 55 65
27. K. Nagai, K. Miyake, and T. Kubota A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth Brain Res. Dev. Brain Res. 157 2005 103 106
28. T.L. Perry, H.G. Dunn, H.H. Ho, and J.U. Crichton Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome J. Pediatr. 112 1988 234 238
29. X. Qian, Q. Shen, S.K. Goderie, W. He, A. Capela, A.A. Davis, and S. Temple Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells Neuron 28 2000 69 80
30. R.C. Samaco, C. Mandel-Brehm, H.T. Chao, C.S. Ward, S.L. Fyffe-Maricich, J. Ren, K. Hyland, C. Thaller, S.M. Maricich, P. Humphreys, J.J. Greer, A. Percy, D.G. Glaze, H.Y. Zoghbi, and J.L. Neul Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities Proc. Natl. Acad. Sci. U. S. A. 106 2009 21966 21971
31. V. Saywell, A. Viola, S. Confort-Gouny, Y. Le Fur, L. Villard, and P.J. Cozzone Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism Biochem. Biophys. Res. Commun. 340 2006 776 783
32. H. Setoguchi, M. Namihira, J. Kohyama, H. Asano, T. Sanosaka, and K. Nakashima Methyl-CpG binding proteins are involved in restricting differentiation plasticity in neurons J. Neurosci. Res. 84 2006 969 979
33. M.D. Shahbazian, B. Antalffy, D.L. Armstrong, and H.Y. Zoghbi Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation Hum. Mol. Genet. 11 2002 115 124
34. R.D. Smrt, J. Eaves-Egenes, B.Z. Barkho, N.J. Santistevan, C. Zhao, J.B. Aimone, F.H. Gage, and X. Zhao Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons Neurobiol. Dis. 27 2007 77 89
35. B. Stevens Neuron-astrocyte signaling in the development and plasticity of neural circuits Neurosignals 16 2008 278 288
36. T. Takahashi, T. Kawai, H. Ushikoshi, S. Nagano, H. Oshika, M. Inoue, T. Kunisada, G. Takemura, H. Fujiwara, and K. Kosai Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting Mol. Ther. 14 2006 673 683
37. T. Temudo, M. Rios, C. Prior, I. Carrilho, M. Santos, P. Maciel, J. Sequeiros, M. Fonseca, J. Monteiro, P. Cabral, J.P. Vieira, A. Ormazabal, and R. Artuch Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment Brain Dev. 31 2009 46 51
38. K. Tsujimura, M. Abematsu, J. Kohyama, M. Namihira, and K. Nakashima Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2 Exp. Neurol. 219 2009 104 111
39. G.L. Wenk Alterations in dopaminergic function in Rett syndrome Neuropediatrics 26 1995 123 125
40. H.Y. Zoghbi, A.K. Percy, D.G. Glaze, I.J. Butler, and V.M. Riccardi Reduction of biogenic amine levels in the Rett syndrome N. Engl. J. Med. 313 1985 921 924
41. H.Y. Zoghbi, S. Milstien, I.J. Butler, E.O. Smith, S. Kaufman, D.G. Glaze, and A.K. Percy Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome Ann. Neurol. 25 1989 56 60